Knowledge, Attitudes and Practices of Safe Handling of CDs
Launched by ASSIUT UNIVERSITY · Feb 27, 2025
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how healthcare workers, like nurses and pharmacists, handle cytotoxic drugs (CDs), which are commonly used in cancer treatment. The study aims to assess the level of exposure these workers have to these potentially harmful drugs and to identify safe practices for handling them. Healthcare workers who have at least one year of experience in a hospital and are involved in direct patient care may be eligible to participate in the trial.
Participants can expect to share their experiences and knowledge about working with these drugs, which can pose health risks if not handled properly. The research is important because it aims to improve safety guidelines and reduce the health risks associated with working with cytotoxic drugs. Understanding these risks and implementing better practices will help protect both healthcare workers and the patients they care for.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthcare workers (nurses and clinical pharmacists) employed in the tertiary care unit.
- • At least one year of work experience in the hospital. Exposure to chemotherapy drugs
- Exclusion Criteria:
- • Healthcare workers not involved in direct patient care or medication administration.
- • Workers with pre-existing conditions that may be influenced by factors unrelated to drug exposure (e.g., other environmental toxins).
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported